Publications from 2021 to 2026
Filter Showing 10 of 358 papers
1Real-world outcomes in patients with cirrhosis undergoing cholecystectomy: a population-based study.
Leveraging Art to Support Refugee Newcomer Families’ Well-Being: A Qualitative Study
There has been a shift toward resettlement in smaller cities, creating potential new challenges, and opportunities, in supporting refugee families. This study used interviews and participant observation to explore health and social impacts of a settlement services–run arts-based therapy group for newcomer families in a small city. A social-ecological approach exploring how the program operated as a third space highlighted potential pathways for supporting newcomer families’ well-being across multiple levels. As a study exploring the intersection of refugee settlement, organizational programming, and well-being, this article contributes to a greater understanding of newcomer supports within a smaller city context.
Read moreWCN26-7011 RISK OF MAJOR ADVERSE CARDIOVASCULAR OUTCOME AMONG CHILDHOOD CANCER SURVIVORS WITH CHRONIC KIDNEY DISEASE OR HYPERTENSION
365P Global patterns and future burden of lung cancer: Worldwide incidence and mortality in 2022 with projections to 2050
401eP Patterns of lung cancer incidence and mortality in Europe: Age- and sex-stratified epidemiology and long-term projections
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 24.
In this update, we review a new bias appraisal tool, explore lessons from a trial emulation study, and describe the development of real-world evidence guidance in the Philippines.
Read moreBeta-Blockers, Angiotensin-Converting Enzyme Inhibitors, and Anaphylaxis.
Investigating nasal interleukin (IL)-33 after the Allergic RhinitisClinical Investigator Collaborative (AR-CIC) nasal allergen challenge.
Drug-induced corneal oedema: amantadine-associated toxicity.
Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
Copyright 2026 Cactus Communications. All rights reserved.
